Clinical Trial Update: Clinical Trial of AVL-3288 in Schizophrenia Patients [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of AVL-3288 in patients with schizophrenia and schizoaffective disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• AVL-3288

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 1 | Status: COMPLETED